Connect with us

Psilocybin

Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial

A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. Using Real World Evidence trials, Albert Labs is…

Published

on

A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. Using Real World Evidence trials, Albert Labs is expecting to legally provide psilocybin to patients in the UK much earlier than companies working with to get FDA approval.

A former Moderna executive has taken a leadership position in MAPS, the largest nonprofit in the psychedelics space.

In Oklahoma, a psilocybin decriminalization bill is headed to the state senate after getting approval from the state's lower chamber.

Albert Labs, Psychedelic Biotech Company Shares Now Available On Canadian Exchange

Albert Labs, a British-Columbia-based biotech company, announced Thursday that it closed its private placement and that its shares will begin trading on the Canadian Securities Exchange (CSE). Albert Labs will trade under the ticker symbol “ABRT.” Read the full story…

Former Moderna Vice President Joins Psychedelics Company In Phase 3 Trials For Ecstasy

Michael Mullette, a former Moderna MNRA vice president is taking a senior leadership position in the MAPS Public Benefit Corporation, a biotech company in the psychedelics sector. Read the full story…

GOP-Led Psilocybin Decriminalization & Research Bill Heads To Oklahoma Senate

A bill to decriminalize low-level possession ...

Full story available on Benzinga.com

Read More

Trending